Feasibility, Accuracy, and Reproducibility of Virtual Reality Visual Field Testing in Patients With Glaucoma
NCT ID: NCT07063537
Last Updated: 2025-07-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
60 participants
INTERVENTIONAL
2024-12-14
2025-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Can both devices produce similar results in terms of detecting visual field defects and progression?
* Does the stage (early, moderate, advanced) of glaucoma impact results between the two devices?
Participants will perform both a standard and a VR based visual field test at each visit, for a total of 5 visits.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Perimetric Testing With Virtual Reality
NCT06549010
Evaluation of a Novel Head-Mounted Device for Glaucoma Testing: A Proof-of-Concept Study
NCT05030714
Comparison of Critical Flicker Fusion Versus Automated Visual Fields in the Detection of Early Glaucoma
NCT01076114
Evaluating Home Testing Devices for the Management of Glaucoma
NCT05325996
Will Listening to Music Make it Easier to Take a Visual Field Test?
NCT01027039
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Each participant will perform visual field testing for both eyes using both the VR visual field system and HFA (order randomized). Five separate sessions (both tests for each patient; both eyes) will be conducted, at least 24 hours apart. Patients will also be asked to fill out a questionnaire to qualitatively evaluate their perception of each visual field test.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Visual Field Testing
Participants will perform both a virtual reality-based visual field test and a standard Humphrey visual field test for both eyes.
Virtual Reality Visual Field (VR-VF)
Both devices administer a standard visual field test. The Humphrey is the gold standard desk top model and the VR-VF is a virtual reality headset designed to deliver visual field testing
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Virtual Reality Visual Field (VR-VF)
Both devices administer a standard visual field test. The Humphrey is the gold standard desk top model and the VR-VF is a virtual reality headset designed to deliver visual field testing
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diagnosis of primary open-angle glaucoma
* ability to perform visual field testing
* capacity to provide informed consent to research protocol
Exclusion Criteria
* previous intraocular surgery (excluding cataract surgery and minimally invasive glaucoma surgery)
* significant media opacity
* pregnancy
* seizure disorder
* cardiac pacemaker/other implantable device
* severe vertigo/balance disorder
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nova Scotia Health Authority
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Brennan Eadie
MD, PhD, FRCSC. Assistant Professor, Glaucoma Division; Department of Ophthalmology and Visual Sciences. Dalhousie University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brennan Eadie, MD, PhD, FRCSC
Role: PRINCIPAL_INVESTIGATOR
Nova Scotia Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eadie Technologies Inc
Halifax, Nova Scotia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Canadian Ophthalmological Society Glaucoma Clinical Practice Guideline Expert Committee; Canadian Ophthalmological Society. Canadian Ophthalmological Society evidence-based clinical practice guidelines for the management of glaucoma in the adult eye. Can J Ophthalmol. 2009;44 Suppl 1:S7-93. doi: 10.3129/cjo44s1. No abstract available. English, French.
Selvan K, Mina M, Abdelmeguid H, Gulsha M, Vincent A, Sarhan A. Virtual reality headsets for perimetry testing: a systematic review. Eye (Lond). 2024 Apr;38(6):1041-1064. doi: 10.1038/s41433-023-02843-y. Epub 2023 Nov 30.
Glen FC, Baker H, Crabb DP. A qualitative investigation into patients' views on visual field testing for glaucoma monitoring. BMJ Open. 2014 Jan 10;4(1):e003996. doi: 10.1136/bmjopen-2013-003996.
Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014 Nov;121(11):2081-90. doi: 10.1016/j.ophtha.2014.05.013. Epub 2014 Jun 26.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1030608
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.